Identification of AFAP1L1 as a prognostic marker for spindle cell sarcomas

Oncogene

Volumn 30, Issue 38, 2011, Pages 4015-4025

  Furu, M ^a,b   Kajita, Y ^a,b   Nagayama, S ^b   Ishibe, T ^a,b   Shima, Y ^a,b   Nishijo, K ^a,b   Uejima, D ^a,c   Takahashi, R ^a,b   Aoyama, T ^a,c   Nakayama, T ^b   Nakamura, T ^b   Nakashima, Y ^d   Ikegawa, M ^e   Imoto, S ^f   Katagiri, T ^f,h   Nakamura, Y ^f   Toguchida, J ^a,b,g  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g KYOTO UNIVERSITY   (Japan)

^h UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

AFAP1L1; metastasis; prognostic marker; spindle cell sarcoma

Indexed keywords

ACTIN FILAMENT SSOCIATED PROTEIN 1 LIKE 1; ANTINEOPLASTIC AGENT; MATRIX METALLOPROTEINASE; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SURGERY; CELL IMMORTALIZATION; CELL INVASION; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SPINDLE CELL SARCOMA; TUMOR GROWTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MICROFILAMENT PROTEINS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 80052969182     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.108     Document Type: Article

References (40)

1. Aoyama T, Okamoto T, Nagayama S, Nishijo K, Ishibe T, Yasura K et al. (2004). Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator, Sp3. J Biol Chem 279: 28789-28797. (Pubitemid 38900164)
2. Baisden JM, Gatesman AS, Cherezova L, Jiang BH, Flynn DC. (2001b). The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases. Oncogene 20: 6607-6616. (Pubitemid 32980287)
3. Baisden JM, Qian Y, Zot HM, Flynn DC. (2001a). The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity. Oncogene 20: 6435-6447. (Pubitemid 32977849)
4. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, DeCarolis PL et al. (2010). Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 42: 715-721.
5. Chibon F, Lagarde P, Salas S, Perot G, Brouste V, Tirode F et al. (2010). Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 16: 781-787.
6. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM et al. (1994). Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7: 502-508. (Pubitemid 24308337)
7. Dorfleutner A, Stehlik C, Zhang J, Gallick GE, Flynn DC. (2007). AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells. J Cell Physiol 213: 740-749. (Pubitemid 350058267)
8. Egeblad M, Werb Z. (2002). New functions for the matrix metallo-proteinases in cancer progression. Nat Rev Cancer 2: 161-174. (Pubitemid 37328786)
9. Francis P, Namlos HM, Muller C, Eden P, Fernebro J, Berner JM et al. (2007). Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics 8: 73.
10. Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M. (2001). Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19: 3045-3050. (Pubitemid 32565442)
11. Fletcher CDM, Unni KK, Mertens F. (2002). Pathology and Genetics of Tumours of Soft Tissue and Bones. IARC Press: Lyon.
12. Flynn DC, Leu TH, Reynolds AB, Parsons JT. (1993). Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate. Mol Cell Biol 13: 7892-7900. (Pubitemid 23354314)
13. Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC. (2004). Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110. Mol Cell Biol 24: 7578-7597. (Pubitemid 39121485)
14. Guappone AC, Flynn DC. (1997). The integrity of the SH3 binding motif of AFAP-110 is required to facilitate tyrosine phosphoryla-tion by, and stable complex formation with, Src. Mol Cell Biochem 175: 243-252. (Pubitemid 27453358)
15. Helman LJ, Meltzer P. (2003). Mechanisms of sarcoma development. Nat Rev Cancer 3: 685-694. (Pubitemid 37328823)
16. Ishibe T, Nakayama T, Aoyama T, Nakamura T, Toguchida J. (2008). Neuronal differentiation of synovial sarcoma and its therapeutic application. Clin Orthop Relat Res 466: 2147-2155.
17. Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR et al. (2005). Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin Cancer Res 11: 2702-2712. (Pubitemid 40569472)
18. Kanner SB, Reynolds AB, Vines RR, Parsons JT. (1990). Monoclonal antibodies to individual tyrosine-phosphorylated protein substrated of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci USA 87: 3328-3332.
19. Kohno Y, Okamoto T, Ishibe T, Nagayama S, Shima Y, Nishijo K et al. (2006). Expression of claudin7 is tightly associated with epithelial structures in synovial sarcomas and regulated by an Ets family transcription factor, ELF3. J Biol Chem 281: 38941-38950. (Pubitemid 46042020)
20. Lee YF, John M, Falconer A, Edwards S, Clark J, Flohr P et al. (2004). A gene expression signature associated with metastatic outcome in human leiomyosarcomas. Cancer Res 64: 7201-7204. (Pubitemid 39372051)
21. Lodyga M, De Falco V, Bai XH, Kapus A, Melillo RM, Santoro M et al. (2009). XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. Oncogene 28: 937-949.
22. Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA et al. (2007). Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 117: 3248-3257. (Pubitemid 350096982)
23. Nagayama S, Fukukawa C, Katagiri T, Okamoto T, Aoyama T, Oyaizu N et al. (2005). Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas. Oncogene 24: 6201-6212. (Pubitemid 43080043)
24. Nagayama S, Katagiri T, Tsunoda T, Hosaka T, Nakashima Y, Araki N et al. (2002). Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res 62: 5859-5866. (Pubitemid 35204746)
25. Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K et al. (2007). Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histio-cytoma. Mod Pathol 20: 749-759. (Pubitemid 46933446)
26. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, O'Connell JX et al. (2002). Molecular characterization of soft tissue tumours: a gene expression study. Lancet 359: 1301-1307. (Pubitemid 34310636)
27. Ottaiano A, De Chiara A, Fazioli F, Talamanca AA, Mori S, Botti G et al. (2005). Biological prognostic factors in adult soft tissue sarcomas. Anticancer Res 25: 4519-4526. (Pubitemid 41729506)
28. Overall CM, Kleifeld O. (2006). Tumour microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6: 227-239. (Pubitemid 43292566)
29. Qian Y, Baisden JM, Westin EH, Guappone AC, Koay TC, Flynn DC. (1998). Src can regulate carboxy terminal interactions with AFAP-110, which influence self-association, cell localization and actin filament integrity. Oncogene 16: 2185-2195. (Pubitemid 28220648)
30. Qian Y, Baisden JM, Zot HG, Van Winkle WB, Flynn DC. (2000). The carboxy terminus of AFAP-110 modulates direct interactions with actin filaments and regulates its ability to alter actin filament integrity and induce lamellipodia formation. Exp Cell Res 255: 102-113. (Pubitemid 30115293)
31. Qian Y, Gatesman AS, Baisden JM, Zot HG, Cherezova L, Qazi I et al. (2004). Analysis of the role of the leucine zipper motif in regulating the ability of AFAP-110 to alter actin filament integrity. J Cell Biochem 91: 602-620.
32. Shibata KR, Aoyama T, Shima Y, Fukiage K, Otsuka S, Furu M et al. (2007). Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25: 2371-2382. (Pubitemid 47480497)
33. Shima Y, Okamoto T, Aoyama T, Yasura K, Ishibe T, Nishijo K et al. (2007). In vitro transformation of mesenchymal stem cells by oncogenic H-rasVal12. Biochem Biophys Res Commun 353: 60-66. (Pubitemid 44958341)
34. St-Pierre Y, Couillard J, Van Themsche C. (2004). Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases. Expert Opin Ther Targets 8: 473-489. (Pubitemid 39359652)
35. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S et al. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
36. Toguchida J, Nakayama T. (2009). Molecular genetics of sarcomas: applications to diagnoses and therapy. Cancer Sci 100: 1573-1580.
37. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE et al. (1992). Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52: 6194-6199.
38. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y et al. (1994). Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-3048. (Pubitemid 24187793)
39. Xu J, Bai XH, Lodyga M, Han B, Xiao H, Keshavjee S et al. (2007). XB130, a novel adaptor protein for signal transduction. J Biol Chem 282: 16401-16412. (Pubitemid 47100390)
40. Zhang J, Park SI, Artime MC, Summy JM, Shah AN, Bomser JA et al. (2007). AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. J Clin Invest 117: 2962-2973. (Pubitemid 47529626)